Table 1. Clinical characteristics of the study groups.
| Healthy Controls | No Neglect | Moderate Neglect | Severe Neglect | |
|---|---|---|---|---|
| Number of subjects | 11 | 10 | 12 | 12 |
| Demographic | ||||
| Age (years) | 69 ±4 | 71 ±3 | 68 ±3 | 69 ±3 |
| Sex (n female) | 8 | 7 | 5 | 3 |
| Clinical | ||||
| Time since stroke (d) | - | 4 ±1 | 4 ±1 | 5 ±1 |
| Type of stroke | ||||
| - Ischaemic (n) | - | 9 | 10 | 11 |
| - Haemorrhagic (n) | - | 1 | 2 | 1 |
| Visual extinction (n) | 0 | 0 | 7 | 11 |
| Functional | ||||
| Catherine Bergego Scale | 0 | 0 | 8±1 | 24±1 |
| mRankin Score | 0 | 2.4 ±0.4 | 3.1 ±0.4 | 4.4 ±0.2 |
| NIH-Stroke Scale | 0 | 3 ±1 | 5 ±1 | 11 ±1 |
| Barthel Index (%) | 100 | 69 ±10 | 53 ±11 | 13 ±5 |
Mean ±sem.